Responses
Other content recommended for you
- Response to: ‘We could be heroes: ethical issues with the pre-recruitment of research participants’ by Hunter
- Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey
- Climate footprint of industry-sponsored clinical research: an analysis of a phase-1 randomised clinical study and discussion of opportunities to reduce its impact
- Delays in dealing with complaints against drug companies are growing, BMJ finds
- Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
- Payment in challenge studies: ethics, attitudes and a new payment for risk model
- What can qualitative research do for randomised controlled trials? A systematic mapping review
- Who is paying your doctor?
- Why have UK doctors been deterred from prescribing Avastin?
- Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled parallel group trial in children recruited from primary care